New hope for aggressive breast cancer: drug combo trial opens
NCT ID NCT06690840
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 26 times
Summary
This study tests a combination of three drugs (atezolizumab, vinorelbine, and cyclophosphamide) in people with advanced triple-negative breast cancer that has spread. Participants must have had immunotherapy before. The goal is to see if this combo can shrink tumors and improve survival. About 45 people will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Sanitaria Locale Br
NOT_YET_RECRUITINGBrindisi, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
European Institute of Oncology
RECRUITINGMilan, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS San Gerardo Dei Tintori
RECRUITINGMonza, Monza, 20900, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NOT_YET_RECRUITINGRoma, Roma, 00168, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NOT_YET_RECRUITINGRoma, Roma, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.